ADVM
|
Adverum Biotechnologies, Inc.
|
US
|
NASDAQ
|
ALC
|
Alcon Inc.
|
US
|
NYSE
|
ALIM
|
Alimera Sciences, Inc.
|
US
|
NASDAQ
|
CLSD
|
Clearside Biomedical, Inc.
|
US
|
NASDAQ
|
GRAY
|
Graybug Vision, Inc.
|
US
|
NASDAQ
|
IRIX
|
IRIDEX Corporation
|
US
|
NASDAQ
|
ISEE
|
IVERIC bio, Inc.
|
US
|
NASDAQ
|
KALA
|
Kala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
KOD
|
Kodiak Sciences Inc
|
US
|
NASDAQ
|
OCGN
|
Ocugen, Inc.
|
US
|
NASDAQ
|
OCUP
|
Ocuphire Pharma, Inc.
|
US
|
NASDAQ
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
DGNOF
|
Diagnos Inc
|
US
|
OTC
|
ESMC
|
Escalon Med Cp
|
US
|
OTC
|
NVSEF
|
Novartis Ag Basl
|
US
|
OTC
|
OXBDF
|
Oxford Biomedical Lt
|
US
|
OTC
|
RNUGF
|
Reneuron Group Plc
|
US
|
OTC
|
RTGN
|
Retinalgenix Technologies Inc
|
US
|
OTC
|
TOPCF
|
Topcon Corp
|
US
|
OTC
|
ADK
|
Diagnos Inc.
|
CA
|
TSXV
|